RDY
$14.19
Dr.
Historical Price
Peer Comparison
Whystock Valuation Model
Fundamentals
Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company North America, Europe, India, Russia, and internationally. It operates through Global Generics, Pharmaceutical Services and Active Ingr...
Recent News
Asian Equities Traded in the US as American Depositary Receipts Rise in Friday Trading
Asian equities traded in the US as American depositary receipts were tracking higher Friday morning,
ESPR's Q4 Earnings Lag Estimates, Revenues Beat, Stock Down
Esperion Therapeutics' Q4 revenues surge 144% to $168.4M but EPS of 22 cents misses estimates. Shares fall as mixed results weigh on sentiment.
Asian Equities Traded in the US as American Depositary Receipts Rebound in Tuesday Trading
Asian equities traded in the US as American depositary receipts were higher Tuesday morning, rising
Zacks Industry Outlook Highlights Teva Pharmaceuticals, Sandoz and Dr. Reddy's
TEVA, Sandoz and Dr. Reddy's are shifting toward complex generics and biosimilars to counter pricing pressure and strengthen margins in the competitive generics market.
Asian Equities Traded in the US as American Depositary Receipts Rise Modestly in Wednesday Trading
Asian equities traded in the US as American depositary receipts were modestly higher Wednesday morni